Much has been written about the demise of the traditional pharmaceutical sales model and the “Complex Buying Environment” that now pervades within our industry. The reasons have been well docu ...

Moderna reported earnings that exceeded expectations due to effective cost management but still has challenges related to its ...

Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 ...

Sales of Wegovy reached 17.3 billion kroner ... a currently approved CAR-T treatment from Johnson & Johnson and Legend Biotech. Parkinsonian symptoms and cranial nerve palsies have been reported ...

Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

If Kevin and Stephanie Ness collect their $15 million asking price for the home on Sunset Blvd., it will be the second time they set a record for selling a Boulder home. In January 2023, the ...

after analysts at JPMorgan Chase & Co. predicted the Danish biotech firm’s experimental weight-loss drug petrelintide could ...

Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last iteration of the shot did in 2023.

Sales for cancer drug Venclexta and antipsychotic ... is a healthcare giant that derives the majority of its growth from its pharmaceutical business. J&J boasts a large product lineup that ...

Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.